Printer Friendly

CLINICAL STUDY OPENINGS.

An investigational drug for treating bipolar I is now being studied at Indiana University Hospital in Indianapolis. To qualify, you must be 18 years of age or older, have a diagnosis of bipolar I disorder, and not have active seizures, heart disease, or other serious or unstable illnesses.

The safety and effectiveness of the new drug will be evaluated during the 13-month study. Qualified volunteers will receive compensation for time and travel, psychiatric evaluation and testing, and free study-related testing. For more information, Indiana residents may call 317-278-0038.
COPYRIGHT 2001 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Update
Date:Mar 1, 2001
Words:88
Previous Article:CHILDHOOD OBESITY: A "BIG" PROBLEM.
Next Article:MEDICAL PROGRESS.
Topics:


Related Articles
OMAPATRILAT REDUCES RISK FOR CONGESTIVE HEART FAILURE PATIENT.
NIH opens doors of hospital dedicated to clinical research.
Disaster nursing and emergency preparedness for chemical, biological, and radiological terrorism and other hazards, 2d ed.
Milk thistle may protect liver of children receiving chemo.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters